Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Schizophr Res. 2015 Sep 2;168(0):456–460. doi: 10.1016/j.schres.2015.08.019

Table 2.

Pearson Correlates of Demographic, Clinical, and Metabolic Risk Factors and hs-CRP in Schizophrenia and Non-Psychiatric Comparison Groups

Variables hs-CRP (mg/L) in Schizophrenia (N = 88) hs-CRP (mg/L) in Non-Psychiatric Comparison Subjects (N = 71)
r p r p
Current Age (Years) -.087 .420 .090 .455
Education (Years) -.016 .881 -.171 .154
Age of Schizophrenia Onset .106 .333 - -
Duration of Illness -.168 .122 - -
Current Antipsychotic Dose (mg CPZE/day) .063 .560 - -
Positive Symptom Factor Score .046 .669 - -
Negative Symptom Factor Score .215 .044 - -
Disorganized Symptom Factor Score .093 .389 - -
Executive Functioning Composite Score -.030 .778 -.246 .039
CIRS Total Score .264 .013 .117 .332
BMI (kg/m2) .317 .006 .661 <.001
Fasting Blood Glucose (mg/dL) .300 .005 .257 .034
Hemoglobin A1c (%) .406 .001 -.008 .950

Note:

BMI = Body Mass Index

CIRS = Cumulative Illness Rating Scale

CPZE = Chlorpromazine Equivalent

hs-CRP = high sensitivity C-Reactive Protein

HHS Vulnerability Disclosure